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The Vacuole Membrane Protein 1 -VMP1- is a pancreatitis-associated transmembrane protein whose
expression triggers autophagy in several human diseases. In the current study, we unveil the mechanism
through which this protein induces autophagosome formation in mammalian cells. We show that VMP1
autophagy-related function requires its 20-aminoacid C-terminus hydrophilic domain (VMP1-AtgD). This
is achieved through its direct binding to the BH3motif of Beclin 1 leading to the formation of a complexwith
the Class III phosphatidylinositol-3 kinase (PI3K) hVps34, a key positive regulator of autophagy, at the site
where autophagosomes are generated. This interaction also concomitantly promotes the dissociation of
Bcl-2, an autophagy inhibitor, from Beclin 1. Moreover, we show that the VMP1-Beclin 1-hVps34 complex
favors the association of Atg16L1 and LC3 with the autophagosomal membranes. Collectively, these
findings reveal that VMP1 expression recruits and activates the Class III PI3K complex at the site of
autophagosome formation during mammalian autophagy.
A
utophagy is an evolutionarily conserved transport pathway that involves the sequestration and delivery of
cytoplasmic material into the lysosome, where it is degraded and recycled1. This catabolic process is
involved in the turnover of long-lived proteins and other cellular macromolecules, and it might play a
protective role in tumor development, aging, cell death, and intracellular pathogen invasions2,3.
Macroautophagy (hereafter autophagy) involves the formation of double-membrane autophagosomes around
the targeted cargoes, which include large structures such as organelles and protein aggregates. Autophagosomes
then fuse with lysosomes exposing their cargoes to the hydrolytic content of this organelles4. This cellular process
essential to maintain cellular homeostasis is regulated in an analogous manner to secretion and endocytosis,
where related molecules on distinct organelle membranes mediate the flux of vesicular transport by protein-
protein interactions. Since the discovery of yeast autophagy-related (Atg) proteins5, autophagosome formation
has been dissected at the molecular level but a lot of questions about the molecular mechanism underlying this
process remain unanswered. Autophagosomes can be considered unique organelles because they do not contain
marker proteins of other subcellular compartments6. In mammalian cells, the sequential association of at least a
subset of the Atg proteins leads to the assembly of the pre-autophagosomal structures (PAS), which is believed to
be the site where the precursor structure of the autophagosomes, the phagophores, are generated7. The PAS and
phagophore formation also requires phosphatidylinositol 3-phosphate (PI3P)8 and it is believed to be associated
to specific subdomains of the endoplasmic reticulum (ER) termed omegasomes9,10. Among the key mediators
initiating autophagosome formation, there is a set of evolutionarily conserved Atg. gene products; the kinase-
containing Ulk1/2 complex (Atg1 in yeast), the Class III phosphatidylinositol 3-kinase (Class III PI3K) complex
(composed by Beclin 1/Atg6-hVps34, hVps15 and Atg14L), the ubiquitin-like conjugation systems leading to the
formation of the Atg5–Atg12–Atg16L1 complex and the LC3/Atg8 phosphatidylethanolamine- conjugate (e.g.
LC3-II)11. A second group of Atg proteins, which does not have orthologous in yeast, has also recently emerged
and appear to play a key role in regulating autophagy in high eukaryotes. One of these proteins is the transmem-
brane Vacuole-Membrane-Protein-1 (VMP1), whose expression triggers autophagy in mammalian cells even
under nutrient-rich conditions12–14. Conversely, autophagy is completely blocked in absence of VMP112.
Crucially, VMP1 is expressed early during the onset of several pathologies, including diabetes mellitus,
pancreatitis and pancreatic cancer12,15,16. Recently, we have reported that VMP1 expression is induced by hyper-
stimulation of Gq-coupled CCK receptor in pancreatic acinar cells during acute pancreatitis14 and by mutated K-
Ras in pancreatic cancer cells17. Its tissue-specific transgenic-expression in vivo prevents pancreatic cell death
induced by acute pancreatitis14. Besides having role in triggering autophagy as a cell response in pathological
situations, VMP1 is required for autophagosome formation inmammalian cells in all conditions7,18. VMP1, along
with Ulk1 and Atg14, localizes to the sites where autophagosome are formed independently of the other Atg
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proteins7 highlighting an upstream function of VMP1 in this process.
We have previously shown that VMP1 is a transmembrane protein
localizing the ER19, where the autophagosome are thought to be
generated10. Therefore, we hypothesized that VMP1 may serve as
a platform that promotes the optimal organization of the Atg
machinery leading to the formation of the PAS and subsequently
of autophagosomes.
Beclin 1 is a haploinsufficient tumor suppressor and an important
effector of autophagy. Beclin 1 is a subunit of the Class III PI3K
complex, the action of which is antagonized by Bcl-220,21. Beclin 1
contains a BH3 domain that mediates its interaction with Bcl-2, but
the avidity of this interaction is quite weak compared to BH3
domains present in the proteins involved in apoptosis regulation22,23.
The interaction between Bcl-2 and Beclin 1 leads to inhibition of
autophagy by interfering with the formation and activity of the
autophagy promoter complex, Beclin 1-PI3K21. In view of the multi-
ples pathways relying on Bcl-2 at the ER and the relatively weak
binding between Bcl-2 and Beclin 1, a mechanism to ensure adequate
partitioning of Beclin 1 to the autophagy pathway must exist.
Mammalian Beclin 1 is present in distinct Class III PI3K complexes24.
Each complex seems to have a core consisting of Beclin 1, hVps34,
and hVps15 and specific interactors, such as Atg14L, UVRAG, or
Rubicon, conferring them distinct functions in membrane traffick-
ing25. The Atg14L-containing PI3K complex is directly involved in
autophagosome formation26–28. The specific molecular mechanism
determining the association of the Class III PI3K complex to the PAS,
however, remains to be fully understood.
In this study, we have elucidated the mechanism through which
Beclin 1 and hVps34 are recruited to the PAS. This event involves the
binding between the 20-aminoacid of the C-terminal hydrophilic
domain of VMP1, which we have called the VMP1 autophagy-
related domain (VMP1-AtgD)12,29, with the BH3 domain of Beclin
1. This interaction leads the formation of a VMP1-Beclin 1-hVps34
complex and the subsequent association of Atg16L1 to the autopha-
gosomal membranes, providing a model describing one of the key
steps in the PAS formation and autophagy regulation in mammalian
cells.
Results
VMP1 interacts with the BH3 domain of Beclin 1. We have
previously demonstrated that the C-terminal domain of VMP1,
VMP1-AtgD (Fig. 1a), is essential for autophagy and for the
interaction with Beclin 112. Therefore, to further delineate the
Figure 1 | VMP1-AtgD interacts with the BH3 domain of Beclin 1. (a) Schematic representation of VMP1 protein primary structure with the position of
six hydrophilic domains. TM, transmembrane domain; AtgD Autophagy related domain. (b) Schematic diagram of Beclin 1 recombinant peptides and
Beclin 1-BD. The predicted functional domains of human Beclin 1 are indicated: BH3, Bcl-2 binding domain; CCD, coiled coil domain; ECD,
evolutionarily conserved domain. (c) Pull-down assays. His6-fused recombinant peptides of Beclin 1 (Beclin 1
1-450; Beclin1/CCD1-269; Beclin1/BH31-123)
bound to nickel-agarose beads were incubated with the VMP1-AtgD purified peptide. Eluates were separated and subjected to Beclin 1 and VMP1-AtgD
immunoblotting. Data are representative of three independent experiments. (d) Pull-down assay using anti-Flag antibody of lysates from cells transfected
with a plasmid encoding for Flag-Beclin-BD incubated with a synthetic VMP1-AtgD peptide. Eluates were separated and subjected to anti-Flag and
anti-VMP1-AtgD immunoblotting. (e) Co-precipitation assays. Lysates fromHeLa cells transfected with pCR3.1-Flag-Beclin 1-BD and pcDNA4-VMP1
expression plasmids were incubated with nickel-agarose beads. After washes, eluted proteins were separated and subjected to Flag, V5 and Beclin 1
immunoblotting (to detect endogenous Beclin 1). (f) Pull-down assays. Lysates fromHeLa cells transfected with VMP1-V5 and Flag-Beclin 1, Flag-Beclin
1 F123A or Flag-Beclin1 I125A were incubated with nickel-agarose beads. Eluates were subjected to SDS-PAGE and immunoblotting using anti-V5 or
anti-Flag antibodies. Data are representative of three independent experiments.
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interaction mechanism between VMP1 and Beclin 1, we have set out
an in vitro assay to determine the domain of Beclin 1 that binds to
VMP1. In a first series of experiments, we performed in vitro pull-
down assays using three different recombinant Beclin 1 peptides
(Fig. 1b) with the VMP1-AtgD synthetic peptide (hydrophilic
C-terminal residues 386–406). We found that all the three
recombinant Beclin 1 peptides (Beclin 11-450, Beclin 1/CCD1-269 and
Beclin 1/BH31-123) were able to bind the VMP1-AtgD synthetic
peptide (Fig. 1c). Taking into account that the BH3 domain is
present in all the three Beclin 1 peptides that bound to VMP1-
AtgD peptide, these results suggested that the BH3 domain is the
one implicated in VMP1-Beclin 1 interaction. We refined our search
by using an expression plasmid encoding the Beclin 1-defective
mutant, i.e. Beclin 1-BDD88-150 (lacking the BH3 domain). First we
performed in vitro pull-down assays with anti-Flag magnetic beads.
Lysates obtained from HeLa cells transfected with the plasmid
expressing Flag-tagged Beclin 1-BDD88-150 were incubated with the
VMP1-AtgD synthetic peptide. Figure 1d shows that Beclin 1-BD
was not able to precipitate the VMP1-AtgD. Then, homogenates
obtained from HeLa cells transfected with the plasmids expressing
Flag-tagged Beclin 1-BD and VMP1-V5-His6-tagged were subjected
to coimmunoprecipitation assays using nickel-agarose beads. As
shown in Figure 1e, VMP1 was not able to bind with the mutant
Beclin 1-BD. Interestingly; VMP1 was able to interact to the
endogenous Beclin 1, which contains the BH3 domain. We
performed additional pull-down assays using a mutant with a
single amino acid substitution in the BH3 domain, the Flag-Beclin
1 F123A, which has been previously shown to disrupt the interaction
of Beclin 1 with Bcl-221. Thus, we evaluate if this mutant is able to
interact with VMP1. Also we evaluated Flag-Beclin 1 I125A, which is
a control mutant. We performed pull-down assays in HeLa cells
transfected with VMP1-V5 and Flag-Beclin 1, Flag-Beclin 1 F123A
or Flag-Beclin 1 I125A expression plasmids. Figure 1f shows that
while Beclin 1 and Beclin 1 I125A are able to interact with VMP1,
Beclin 1 F123A does not co-isolate with VMP1; confirming that the
BH3 domain of Beclin 1 is required for VMP1-Beclin 1 interaction.
Collectively, these results demonstrate that VMP1 is able to interact
with the BH3 domain of Beclin 1.
VMP1 interacts with Beclin 1 in vivo in human cells. In order to
confirm VMP1-Beclin 1 in vivo interaction in human cells, we used
the fluorescence resonance energy transfer (FRET) analysis by using
acceptor photo-bleaching method30, an established technique that
relies on close spatial proximity of fluorescent molecules (see
Materials and Methods). Evidence of increased donor fluorescence
after photo-bleaching, indicates energy transfer between the donor
and the acceptor, which can only occur when the donor-acceptor
distance is less than 10 nm, a distance that is too short to be occupied
by another protein. The FRET constructs were made tagging YFP to
the VMP1 C-terminus and CFP to Beclin 1 N-terminus (Fig. 2a).
Plasmids encoding CFP-Beclin 1 and VMP1-YFP were transiently
transfected into HeLa cells, and the CFP and YFP fluorescent signals
were acquired before (Fig. 2b; top panel) and after photo-bleaching
(Fig. 2b; bottom panel). Confocal images of CFP-Beclin 1 are
typically and noticeable brighter in fluorescence intensity after
photo-bleaching the YFP fused to VMP1 (Fig. 2b). The pseudo-
color images represent the increase of pixel density before and
after bleaching. The color in the bar represents the pixel density of
the image and thus the intensity of interaction, indicating an in vivo
interaction between VMP1 and Beclin 1 (Fig. 2b). As a negative
control, we employed the CFP-Beclin 1-BD fusion, which lacks the
BH3 domain. Figure 2c shows that when VMP1-YFP was bleached,
there was no increase in CFP-Beclin 1-BD signaling (bottom panel).
Accurate quantification of the signals Fig. 2d showed that the average
energy transfer efficiency for the cells expressing CFP-Beclin 1-BD
with photo-bleached acceptors was 12.7% compared with 57% in the
ones carrying CFP-Beclin 1. Taken together, our results confirm that
VMP1 interacts with Beclin 1 in vivo.
Previous studies have shown that rapamycin induces autophagy
via VMP1 expression12. Therefore, we explored whether endogenous
VMP1 interacts with the BH3 domain of Beclin 1 during rapamycin-
induced autophagy. HeLa cells were transfected with a vector expres-
sing Flag-tagged Beclin 1 or Beclin 1-BD, and coimmunoprecipita-
tion assays were performed using anti-Flag antibodies bound to
magnetic beads. In cells treated with rapamycin and expressing
Flag-Beclin 1, VMP1 was coimmunoprecipitated with Beclin 1
(Fig. 2e). In contrast, Flag-Beclin 1-BD was not able to immunopre-
cipitate endogenous VMP1 under the same conditions (Fig. 2e).
Together, these results demonstrate that the interaction between
endogenous VMP1 and the BH3 domain of Beclin 1 occurs during
autophagy in mammalian cells.
VMP1 releases Bcl-2 from Beclin 1, driving Beclin 1 into the
autophagy pathway. It has been demonstrated that Beclin 1
interacts with Bcl-2 through its BH3 domain21,23,31. This interaction
is reduced when autophagy is stimulated by nutrient deprivation and
the dissociation between Beclin 1-Bcl-2 is crucial for autophagy
induction21,32. To evaluate the relevance of the VMP1-Beclin 1
interaction in this regulatory context we studied whether VMP1
promotes the dissociation of Beclin 1-Bcl-2 complex upon
autophagy induction. We thus performed coimmunoprecipitation
experiments in cells co-expressing Flag-Beclin 1, GFP-Bcl-2 and
VMP1-V5 or VMP1DAtgD-V5. Cell lysates were incubated with anti-
Flag antibodies bound to magnetic beads and the eluates were
subjected to immunoblot analyses. In cells expressing Beclin 1 and
Bcl-2, Bcl-2 was coimmunoprecipitated with Beclin 1 (Fig. 3a) while
in cells expressing VMP1 and Beclin 1, VMP1 was co-isolated with
Beclin 1 (Fig. 3a). Importantly, in lysates of cells simultaneously
expressing VMP1, Beclin 1 and Bcl-2; Beclin 1 was found
associated with VMP1 but not with Bcl-2. As expected, in cells
expressing VMP1DAtgD (which lack the Atg domain and is not able
to interact with Beclin 1)12, Bcl-2 co-immunoprecipitated with Beclin
1 (Fig. 3a). To confirm that VMP1 regulates the disruption of the
Bcl-2-Beclin 1 complex, we evaluate the role of endogenous VMP1
during rapamycin-induced autophagy using a specific siRNA
to knock down VMP1 expression in HeLa cells. We found that
the levels of Bcl-2-Beclin 1 colocalization was increased in cells
transfected with VMP1 siRNA, but not in cells transfected with
scramble siRNA (Fig. 3b and 3c). Collectively, these results
indicate that under autophagy VMP1 expression promotes the
dissociation between Beclin 1 and Bcl-2 probably through binding
competition.
In order to evaluate the ability of VMP1 to drive Beclin 1 function
into autophagy, HeLa, PANC-1 and AR42J cells cultured in presence
of nutrients and growth factors, were co-transfected with plasmids
expressing RFP-LC3, a marker protein for autophagosomal mem-
branes, and VMP1-YFP and/or GFP-Bcl-2 before determining the
percentage of cells with RFP-LC3 puncta. As expected, the number of
RFP-LC3-positive puncta per cell was significantly higher in cells
expressing VMP1 than in those expressing Bcl-2. Interestingly, the
distribution pattern of RFP-LC3 in cells that co-expressedVMP1 and
Bcl-2 was identical to the one in cells expressing VMP1 alone
(Fig. 4a). Representative confocal images are shown below bars in
Fig 4a. During autophagy, the cytosolic form of LC3, e.g. LC3-I
undergoes first a C-terminus proteolytic cleavage and then a lipid
modification on autophagosomal membrane to become LC3-II31,33.
Thus tomeasure autophagy induction in cells expressing VMP1 and/
or Bcl-2, we analyzed LC3-I conversion into LC3-II by western blot.
As expected and in accordance with the literature21, we found
increased LC3-II levels in cells transfected with the VMP1 construct.
Similarly, cells co-expressing VMP1 and Bcl-2 were more prone to
autophagy induction than Bcl-2 expressing cells (Fig. 4b, lanes 4 and
www.nature.com/scientificreports
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5, and 4c). Then we evaluated LC3 processing in VMP1DAtgD and Bcl-
2 expressing cells. As expected, VMP1DAtgD was not able to increase
LC3-II levels (Fig. 4d and 4e, lane 2). Analogous results were
obtained in pancreatic PANC-1 and AR42J cells (data not shown).
We concluded that under autophagy-inducing condition, VMP1 is
involved in the dissolution of Bcl-2-Beclin 1 complex, necessary for
the Beclin 1-mediated induction of autophagy.
Identification of the VMP1-Beclin 1-hVps34 complex acting in
autophagy. VMP1 expression triggers autophagosome formation12
and it has been shown that this protein localizes at the PAS together
with Ulk1 and Atg14L7. Beclin 1 participates in autophagy as part of
the Atg14L-containing Class III PI3K complex34–36. Generation of
PI3P by this complex is crucial for the recruitment of several other
Atg proteins onto autophagosomal membranes36. To further
delineate the VMP1-Beclin 1 interaction during autophagy, we
carried out coimmunoprecipitation assays to test whether the Class
III PI3K complex is associated with VMP1. First, lysates from HeLa
cells transfected with plasmid expressing Flag-Beclin 1 and VMP1-
V5-His6 or VMP1DAtgD-V5-His6 were incubated with anti-Flag
antibody bound to magnetics beads. As shown in Figure 5a, VMP1
and endogenous hVps34 co-immunoprecipitate with Beclin 1 in cells
expressing VMP1. On the contrary, in cells expressing VMP1DAtgD,
neither VMP1 nor hVps34 were coisolated with Beclin 1 (Fig. 5a).
These results indicate that VMP1 is part of the Class III PI3K
complex during autophagy. Next, HeLa cells transfected with
Figure 2 | FRET analysis of VMP1-Beclin 1 in vivo interaction. (a) Schematic representation of the FRET pair used: CFP tagged N-terminal of Beclin 1
and YFP tagged c-terminal of VMP1. (b) In vivo detection of interaction of VMP1-YFP and CFP-Beclin 1 by acceptor photo-bleaching FRET. VMP1-YFP
and CFP-Beclin 1 were transiently transfected into the HeLa cells. Images were acquired before (top panels: CFP-Beclin 1 and VMP1-YFP) and after
(bottom panels: CFP-Beclin 1 and VMP1-YFP) photo-bleaching the VMP1-YFP. (c) CFP-Beclin 1-BD was used as a negative control. Images were
acquired before (top panels: CFP-Beclin 1-BD and VMP1-YFP) and after (bottom panels: CFP-Beclin1-BD and VMP1-YFP) photo-bleaching of VMP1-
YFP. Pseudo-colored images are shown in both cases indicating the intensity of interaction. (d) The bar graphs represent FRET efficiency. All data are
represented asmean6 SD. Asterisks indicate a significant difference in the Student’s t-test (**p, 0.01). (e) Coimmunoprecipitation assays. Lysates from
HeLa cells treated with rapamycin (2 h) and transfected with pSG5-Flag-Beclin 1 or pCR3.1-Flag-Beclin 1-BD expression plasmids were incubated with
anti-Flag-magnetics beads. Eluted proteins were separated and subjected to anti-Flag and anti-VMP1 immunoblotting. Bar, 10 mm. Data are
representative of three independent experiments.
www.nature.com/scientificreports
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Flag-Beclin 1-BD and VMP1-V5 were incubated with anti-Flag
antibody bound to magnetics beads. Surprisingly, neither VMP1
nor hVps34 were able to co-immunoisolate with Beclin 1-BD
(Fig. 5b), suggesting that VMP1-Beclin 1 interaction may be
involved in the mammalian PI3K complex formation during
autophagy. Then, we treated HeLa cells with rapamycin and using
anti-Beclin 1 or anti-VMP1 antibodies bound to magnetic beads we
evaluated the formation of the VMP1-Beclin 1-hVps34 complex.We
found that during rapamycin-induced autophagy Beclin 1 is able to
coimmunoprecipitate with endogenous VMP1 and hVps34 (Fig. 5c),
and VMP1 coimmunoprecipitates with endogenous Beclin 1 and
hVps34 (Fig. 5d). Unfortunately, our system failed to detect
endogenous Atg14L in the whole homogenates as well as in VMP1
or Beclin 1 immunoprecipitates from rapamycin treated cells (data
not shown). Finally, HeLa cells were transfected with the VMP1-V5-
His6 construct and lysates were precipitated using nickel-agarose
beads. Resulting precipitates were subjected to SDS-PAGE and
silver nitrate staining. Bands corresponding to molecular weights
suggesting the co-isolation of hVps34 (129kDa), Atg14L (65kDa),
and Beclin 1 (55kDa) were present in the VMP1 precipitate (Fig. 5e).
Collectively, results described above, allow us to propose that VMP1
is associated to the autophagy-specific PI3K complex during mam-
malian autophagy.
The VMP1-Beclin 1 complex promotes PI3P generation on
autophagosomal membranes. To test whether the VMP1-Beclin 1
interaction regulates the generation of PI3P in the autophagosomal
membranes; we analyzed PI3K activity in cells expressing either
VMP1 or VMP1DAtgD. The production of PI3P by Class III PI3K
can be visualized and quantified using the GFP-tagged double
FYVE domain of the Hrs protein36,37, which specifically binds to
PI3P. We thus used the GFP-2xFYVE probe to detect PI3P
synthesis on autophagosomal membranes identified with RFP-
LC3. HeLa cells were co-transfected with plasmids expressing
GFP-2xFYVE, RFP-LC3 and VMP1-V5 or VMP1DAtgD-V5. We
found a remarkable colocalization between 2xFYVE and LC3 in
cells undergoing autophagy triggered by VMP1 expression (Fig. 6a
left panel), revealing that VMP1 is able to recruit the activity of the
PI3K complex to the autophagosomal membranes. On the contrary,
the VMP1DAtgD mutant failed to recruit the PI3K complex onto
autophagosomal membranes, since almost no colocalization
between 2xFYVE and RFP-LC3 was found (Fig. 6a right panel).
Moreover, quantification of GFP-2xFYVE puncta per cell revealed
that PI3P production was significantly diminished in VMP1DAtgD-
expressing cells compared to VMP1-expressing cells (Fig. 6b).
These data indicate that the Atg domain of VMP1 is required
to recruit PI3K activity to the autophagosomal membrane.
Subsequently, we evaluated PI3K activity when VMP1 endogenous
expression is activated under rapamycin-induced autophagy before
and after downregulation of VMP1 expression12. Figure 6d upper
panel shows that GFP-2xFYVE positive puncta colocalizes with
LC3 in rapamycin-treated cells. On the contrary, almost no
colocalization between 2xFYVE and LC3 was found after
downregulation of VMP1 expression in rapamycin-treated cells
(Fig. 6d bottom panel). We then transfected VMP1-knocked-down
cells with pcDNA4-VMP1 or pcDNA4-VMP1DAtgD under rapamycin
treatment. Figure 6e shows that VMP1 expression is able to rescue
the generation of PI3P in autophagosomal membranes. Remarkably,
VMP1DAtgD expression was not able to rescue VMP1 mediated
recruitment of PI3K activity to the autophagosomal membrane.
These results demonstrate that VMP1 is essential for the
localization of PI3K activity to the PAS in mammalian autophagy
and confirm that the interaction between the Atg domain of VMP1
and Beclin 1 is required for bringing the mammalian Beclin 1 –PI3K
complex activity to the site of autophagosome formation.
The generation of PI3P by the Class III PI3K complex is crucial for
the recruitment of several other Atg proteins onto autophagosomal
membranes36–38. To monitor this event, we decided to analyze the
Figure 3 | VMP1 displaces Bcl-2 from the BH3 domain of Beclin 1. (a) Coimmunoprecipitation assays. Lysates fromHeLa cells transfected with pSG5-
Flag-Beclin 1, pEGFP-Bcl-2 and pcDNA4-VMP1 or pcDNA4-VMP1DAtgD expression plasmids incubated with anti-Flag-magnetics beads. Eluted proteins
were separated and subjected to Beclin 1, VMP1 and Bcl-2 immunoblotting. (b) Representative confocal microscopy images of HeLa cells co-transfected
with Beclin 1-RFP, GFP-Bcl-2 and treated with rapamycin under/without VMP1 knockdown expression. (c) Percentage of Bcl-2 spots colocalizing with
Beclin 1. The panels on the right show an enlarged view of the boxed regions on the left. Bar, 10 mm. (d) The VMP1 knocking down was validated by
western blot analysis. Results represent mean 6 SD for combined data from four independent experiments.
www.nature.com/scientificreports
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localization of Atg16L1 to the PAS. Therefore, HeLa cells were trans-
fected with a plasmid expressing VMP1-GFP or VMP1DAtgD-GFP
before investigating endogenous Atg16L1 localization by immuno-
fluorescence. Figure 7a shows that VMP1 partially colocalizes with
Atg16L1 during VMP1-induced autophagy. On the contrary
VMP1DAtgD fails to colocalize with Atg16L1 (Fig. 7a), suggesting that
VMP1-Beclin 1 complex formation is required for Atg16L1 local-
ization to the PAS. It has been reported that Atg16L1 form a complex
with Atg12-Atg5 that is involved in determining the site of Atg8/LC3
lipidation32,38. We then investigated whether VMP1-induced LC3
recruitment onto autophagosomal membranes depends on the
Atg12-Atg5-Atg16L1. Accordingly, we simultaneously transfected
Atg52/2 and wild-type, mouse embryonic fibroblasts (MEFs) with
plasmid expressing VMP1-GFP and RFP-LC3. Surprisingly, we
found a remarkable accumulation of large VMP1 labeledmembranes
in Atg52/2 MEFs, most of which were negative for the RFP-LC3
PUNCTA. (Fig. 7b). Then, HeLa cells were transfected with VMP1
after downregulation of Atg5 expression using a specific shRNA.
Figure 7c shows accumulation of VMP1 in large membrane struc-
tures in Atg5 silenced cells. Further, we transfected HeLa cells with
VMP1 and Beclin 1 expression plasmids after downregulation of
Atg5 expression to determine whether Beclin 1 was still recruited
to the PAS by VMP1 in absence of Atg5. We found that Atg5-
depleted cells displayed VMP1-Beclin 1 complex accumulation in
puncta also of large size (Fig. 7d). These findings indicate that
VMP1-Beclin 1 complex acts upstream of the Atg12-Atg5-
Atg16L1 complex during autophagosome formation. Collectively,
the above-described results demonstrate that VMP1 expression,
through the interaction with Beclin 1, regulates the generation of
PI3P on the autophagosomal membranes promoting the localization
of other Atg proteins to the PAS, including Atg16L1 and LC3.
Discussion
In previous works we have demonstrated that VMP1 expression
triggers autophagy and that this transmembrane protein is essential
for autophagosome formation in mammalian cells12. In the current
study, we report that autophagy induction by VMP1 expression is
mediated through the interaction between the VMP1-AtgD and the
Beclin 1-BH3 domains. This event allows the localization of the Class
III PI3K activity on the autophagosome formation site, i.e. the PAS.
We have also demonstrated that the binding of the VMP1-AtgD
domain to the Beclin 1 BH3 motif promotes the displacement of
Bcl-2, a negative regulator of autophagy, driving Beclin 1 to the
autophagic pathway. VMP1-AtgD is required for both forming the
VMP1-Beclin 1-hVps34 complex and inducing the formation of
PI3P on the autophagosomal membranes. Finally, VMP1-Beclin 1-
hVps34 complex, favors the localization of Atg16L1 and LC3 to the
PAS. These findings collectively reveal that VMP1 is part of the
Beclin 1-Class III PI3K complex that regulates autophagy in mam-
malian cells at least under certain conditions.
To the best of our knowledge VMP1 is the only transmembrane
Atg protein with no homologue in yeast and other low eukaryotes.
Our data have revealed that the interaction between VMP1 and
Beclin 1 requires Beclin 1 BH3 domain. Interestingly, Atg6/Vps30,
the yeast homologue of Beclin 1, does not possess a BH3 motif.
Another protein that associates with the BH3 domain of Beclin 1 is
Figure 4 | VMP1-Beclin 1 interaction favors autophagosome formation. (a) HeLa cells co-transfected with RFP-LC3, VMP1-YFP and GFP-Bcl-2.
Fluorescence microscopic quantitation of autophagy (% cells with RFP-LC3 dots) was determined as described under ‘‘Materials and methods’’.
Representative images of HeLa cells co-transfected with RFP-LC3, VMP1-YFP and/or GFP-Bcl-2 are shown below graphic bar. (b) Lysates of pcDNA4-
VMP1 and GFP-Bcl-2 plasmid-transfected HeLa cells with or without vinblastine treatment were analyzed by western blot. LC3-I (apparent mobility,
18kDa) and LC3-II (16kDa), VMP1, Bcl-2 and Actin proteins were determinated. (c) Quantification of protein signal intensities from western blots
showing LC3-II levels after normalization to the control protein Actin. (d) Lysates of pcDNA4-VMP1 and pcDNA4-VMP1DAtgD plasmid-transfectedHeLa
cells were analyzed by western blot. LC3-I (apparent mobility, 18kDa) and LC3-II (16kDa) were determinated. (e) Quantification of protein signal
intensities from western blots showing LC3-II levels after normalization to the control protein Actin. Results represent mean 6 SD for combined data
from four independent experiments. Asterisks indicate a significant difference versus control in two-way ANOVA (**p, 0.01).
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Bcl-2. Binding of Bcl-2 to Beclin1 inhibits autophagy and accordingly
the dissociation of Bcl-2 from Beclin 1 is an important regulatory
event to induce this pathway39. During normal growth conditions
Bcl-2 binding to Beclin 1 is maximal, and when autophagy is induced
this interaction is strongly reduced21. Here, we found that VMP1
expression leads to the dissolution of the Beclin 1-Bcl-2 complex,
indicating that VMP1 is involved in driving Beclin 1 into the autop-
hagic process by removing the negative regulator Bcl-2. Thus, we
propose that VMP1, through the interaction with the BH3 domain
of Beclin 1, regulates the initial steps of autophagy in mammalian
cells.
Recent findings provide biochemical evidence that Beclin 1 is
present in distinct Class III PI3K complexes25. These Beclin 1 com-
plexes are involved at different stages of autophagy and/or of the
endocytic trafficking. Each complex has a core consisting of Beclin
1, hVps34, and hVps15. Our results identify VMP1 as a new inter-
actor of one or more Beclin 1-hVps34 complex, and provide a pos-
sible idea about how the Beclin 1-hVps34 complex could control
autophagosome formation. Our results suggest that VMP1-Beclin
1 interaction is required for the formation of the VMP1-Beclin
1-hVps34 complex during mammalian autophagy. VMP1 can be
immunoprecipitated with both Beclin 1 and hVps34, but Beclin 1
fails to coprecipitate with hVps34 when VMP1 lacks its Atg domain
(Fig. 5a). These data may appear inconsistent with previously pub-
lished data proposing a direct association between Beclin 1 and
hVps3434,43. However, those results were obtained in cells undergoing
autophagy25, and during autophagy is when the VMP1-Beclin 1
interaction occurs12. Indeed, Beclin 1 is not able to coisolate with
hVps34 when its BH3 domain is interacting with Bcl-221. These data
are consistent with our results, because when autophagy is not
induced (Fig. 5c, 5d) or Beclin 1 is not able to interact with VMP1
(Fig.5b), Beclin1-hVps34 complex is not detectable.
Atg14L is another component specifically associated with the
Beclin 1-containing PI3K complex involved in the autophagosome
biogenesis24,26. The antibodies in our possession unfortunately failed
to detect endogenous Atg14L in cell extracts from either rapamycin-
or VMP1-treated cells. However, a band of 65kDa was found in the
eluates when we tried to overcome this problem by performing large
scale pull-down done using VMP1 as bait, suggesting that Atg14L
could be part of the VMP1-Beclin 1-hVps34 complex. Our results
are consistent with the findings of Itakura and co-workers7, which
reported that VMP1 co-localizes with Atg14L at the PAS. To our
knowledge, this is the first study analyzing the endogenous proteins
involved in the formation of the Class III PI3K complex.
We found that the VMP1-Beclin 1 complex promotes PI3P gen-
eration on autophagosomal membranes. Our data show partial but
remarkable co-localization between LC3 and Hrs 2XFYVE upon
rapamycin treatment and VMP1 expression. These findings seem
Figure 5 | Identification of the VMP1-Beclin 1-hVps34 complex. (a) Coimmunoprecipitation assays. Lysates from HeLa cells transfected with pSG5-
Flag-Beclin 1 and pcDNA4-VMP1DAtgD or pcDNA4-VMP1 expression plasmids incubated with anti-Flag covalently bound to magnetic beads. After
washes, eluted proteins were separated and subjected to anti-Beclin 1, V5 and hVps34 immunoblotting. (b) Coimmunoprecipitation assays. Lysates from
HeLa cells transfected with pCR3.1-Flag-Beclin 1-BD and pcDNA4-VMP1 expression plasmids incubated with anti-Flag covalently bound to magnetic
beads. After washes, eluted proteins were separated and subjected to anti-Flag, V5 and hVps34 immunoblotting. (c) Coimmunoprecipitation assays.
Lysates fromHeLa cells treated with rapamycinwere incubatedwith anti-Beclin 1 antibody. Eluted proteins were subjected to anti-Beclin 1, anti-VMP1 or
anti-hVps34 antibody. (d) Coimmunoprecipitation assays. Lysates from HeLa cells treated with rapamycin were incubated with anti-VMP1 antibody.
Eluted proteins were subjected to anti-VMP1, anti-Beclin 1 or anti-hVps34 antibody. (e) HeLa cells transfected with a plasmid harboring pcDNA4-
VMP1-V5 were coprecipitated using nickel-agarose beads. pcDNA4-VMP1DAtg expressing cells were used as control. The precipitates were subjected to
SDS-PAGE and silver nitrate staining. Data is representative of three independent experiments.
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to be different from data published by Axe, et al.9, which suggest that
multiple pools of PI3P, apart from the endoplasmic reticulum, are
labeled by 2xFYVE during amino acid starvation. Nevertheless,
rapamycin treatment or VMP1 overexpression may favor the PI3P
generation in the autophagosome formation site. In fact, we demon-
strated that endogenous VMP1 expression is required for the
docking of the PI3K complex to autophagosomal membranes
since 2xFYVE did not colocalize with these intermediates when
VMP1 expression is downregulated under rapamycin treatment.
Moreover, VMP1DAtgD mutant failed to rescue rapamycin treated
cells from VMP1 down-regulation (Fig. 5e), supporting that the
VMP1-Beclin 1 interaction through the VMP1-AtgD is required
for the proper localization of PI3K activity during mammalian
autophagy.
In mammalian cells, Atg16L1 associated with the Atg12-Atg5
conjugated is involved in determining the site of Atg8/LC3 lipida-
tion32,38. The two conjugation systems are closely related, as Atg12–
Atg5-Atg16L1 is necessary for the efficient LC3 lipidation in vivo and
in vitro40,41. Our findings suggest that VMP1-Beclin 1 interaction
regulates membrane association of the Atg12-Atg5-Atg16L1 com-
plex during autophagy in agreement with data obtained in yeast42.
We demonstrate that VMP1 promotes the generation of PI3P favor-
ing the localization of Atg16L1 and LC3 to the PAS during autopha-
gosome formation. Consistently, we also found that PI3K activity
Figure 6 | The VMP1-Beclin 1 complex promotes PI3P generation in the autophagosomalmembranes. (a) Representative confocal microscopy images
of HeLa cells co-transfected with plasmids encoding for GFP-2xFYVE, RFP-LC3 and VMP1-V5, VMP1DAtgD-V5. Colocalization images were evaluated
using the Colocalization Scatterplot. (b) The presence of VMP1 or VMP1DAtgD in lysates corresponding to the experiments in ‘‘a’’ was evaluated by
immunoblotting using VMP1 antibody. (c) The percentage of cells with GFP-2xFYVE puncta was determined in cells expressing VMP1 or in VMP1DAtgD.
Asterisks indicate a significant difference versus VMP1 in two-way ANOVA (*p, 0.05). (d) Representative confocal images of HeLa cells under
rapamycin treatment after downregulation of VMP1 expression using a specific VMP1 siRNA. (e) VMP1 expressionwas downregulated using the specific
siRNA in HeLa cells treated with rapamycin. After 2 hours of treatment cells were transfected during 24 h with pcDNA4-VMP1 or pcDNA4-VMP1DAtgD.
Bar, 10 mm. Data is representative of three independent experiments.
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Figure 7 | VMP1-Beclin 1 complex is upstream of the Atg12-Atg5-Atg16L1complex. (a) HeLa cells cultured under nutrient and grown factor-replete
conditions and transfectedwith theVMP1-GFP or theVMP1DAtgD-GFP plasmids. Endogenous Atg16L1was analyzed by immunofluorescence by confocal
microscopy. Merge image and two hot fluorescence spots profile are shown to prove specific colocalization. (b) Representative images of MEF Atg52/2
and wild-type cells concomitantly transfected with VMP1-GFP and RFP-LC3 expressing plasmids and observed in a fluorescence microscope. (c) HeLa
cells were transfected with RFP-VMP1 after downregulation of Atg5 using a specific shRNA. (d) HeLa cells concomitantly transfected with RFP-VMP1,
CFP-Beclin 1 and shRNA-Atg5 or shRNA-Scramble. The panels on the right and bottom show an enlarged view of the boxed regions. (e) Western blot
shows downregulation of Atg5 inHeLa cells transfected with shAtg5. Bar, 10 mm.Data in a-e are representative of four independent experiments. (f) This
panel illustrates the proposedmodel of VMP1-Beclin 1 autophagy induction: (1) VMP1 expression is induced. (2) The autophagy-specific PI3K complex
is recruited to the PAS and generates PI3P. (3) The Atg12-Atg5-Atg16L1 complex is recruited. (4) Lipidation and localization of LC3 at the PAS.
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 3 : 1055 | DOI: 10.1038/srep01055 9
does not localize to the autophagosomal membranes when VMP1 is
not able to interact with Beclin 1. Our data also indicate that the
VMP1-Beclin 1 complex functions upstream of Atg16L1 complex.
This notion is also supported by the observation that the VMP1-
Beclin 1 complex accumulates in membrane structures, probably
an autophagosomal precursor, when Atg5 is downregulated. Al-
together, our findings suggest that VMP1 allows the PI3P-enriche-
ment at the PAS and trigger autophagosome biogenesis by recruiting,
forming and possibly activating the VMP1-Beclin 1-hVps34 com-
plex. The formation of the VMP1-Beclin 1-hVps34 complex favors
the recruitment of Atg16L1 and LC3 to promote proper autophago-
some formation (Fig. 7f).
Remarkably, VMP1 expression triggers autophagosome forma-
tion in mammalian cells even under nutrient-replete conditions12.
Pathological processes such as pancreatitis12 and diabetes mellitus16
as well as tumor-cell transformation activate VMP1-mediated autop-
hagy in human tissues and tumor-cell lines15,17. In particular, while
human normal pancreas does not express detectable VMP1 levels,
pancreatic diseases activate VMP1-mediated autophagy. Data pre-
sented here show VMP1 being a key regulator of the early steps of
autophagosome formation in mammalian cells possibly acting as a
scaffold protein. These characteristics collectively point at VMP1 as a
unique Atg protein that regulates autophagy induction in numerous
human diseases. Our findings thus set the bases for future studies on
the regulation of autophagy in pathological situations and highlight
VMP1 as a positive target for therapeutic interventions.
Methods
Mammalian cell lines, transfections and treatments. Human HeLa cell line,
pancreatic cancer cell lines PANC-1, rat pancreatic AR42J and Mouse Embryonic
Fibroblast, (MEF) Atg52/2 or MEF wild-type cells were used. Cells were transfected
using FuGENE-6 reagent (Promega) as indicated by the manufacturer. Cells were
incubated for 24 h in DMEM supplemented with 10% FBS in plates at 80%
confluence and then transfected. Cells were treated with 55 mM rapamycin
(Calbiochem) for 2 h. For inhibition of autophagosome-lysosomal fusion, cells were
incubated with 0.05 nM vinblastine (Sigma).
VMP1-AtgD. The synthetic 20-aminoacid-carboxiterminal hydrophilic peptide
(residues 386–406) was used for pull-down assays and to develop the Rabbit anti-
VMP1-AtgD.
Plasmids. Plasmids pRFP-LC3, pSG5-Flag-epitope-tagged human Beclin 1,
pGFP-Bcl-2, pCR3.1-Flag-Beclin 1–BD21 and pGFP-2xFYVE (Fab1, YOTB, Vac1,
and pEEA1-domain) were kindly provided by Dr. Maria I. Colombo (Universidad
Nacional de Cuyo, Consejo Nacional de Investigaciones Cientı´ficas y Te´cnicas
(CONICET), Argentina). pCR3.1-Flag-Beclin1 F123A and pCR3.1-Flag-Beclin1
I125A were kindly provided by Dr. Beth Levine (UT Southwestern Medical Center,
Texas, United States). pcDNA4-V5-His6 (Invitrogen) containing full-length rat
VMP1 cDNA (NM_138839) or VMP1DAtgD, deficient mutant, in which the VMP1
C-terminus peptide (aa 378–406) was deleted as was described in Ropolo et al.12
pEGFP-VMP1, pEGFP-VMP1DAtgD, pYFP-VMP1, pRFP-VMP1, pRFP-Beclin 1,
pCFP-Beclin 1 and pECFP-Beclin1-BD were designed and constructed by our
laboratory. Atg5 down-regulation was made using the plasmid pCMS3-H1p-EGFP,
which was kindly provided by Dr D. Billadeau (Department of Immunology, College
ofMedicine,Mayo Clinic, United States). The plasmid contains an Atg5 short hairpin
RNA construction (sense 59-GCAACUCUGGAUGGGAUUG-39, and antisense
59- CAAUCCCAUCCAGAGUUGC-39) or a scramble sequence, and a separate
transcriptional cassette for EGFP to identify transfected cells. Cells were also
transfected using Oligofectamine (Invitrogen) with siRNA pre-designed for human
VMP1 mRNA using 59-GGCAGAAUAUUGUCCUGUGtt-39, as sense, and
59-CACAGGACAAUAUUCUCUGCCtt-39, as antisense (Ambion ID32935).
Antibodies. Polyclonal goat anti-LC3, goat anti-Beclin 1 (Santa Cruz Biotechnology,
Inc.); rabbit anti-Flag, rabbit anti-Bcl-2 (Sigma-Aldrich); monoclonal mouse anti-V5
and rabbit anti-hVps34 (Invitrogen); and rabbit anti-Atg16L1 (ABR), were used
accordingmanufacturer. Rabbit anti-VMP1-AtgD (residues 386–406) was developed
in our laboratory. Anti-mouse Alexa Fluor 594 (Molecular Probes) antibody was used
for immunofluorescence. Peroxidase-labeled anti-rabbit, anti-mouse, and anti- goat
IgG antibodies were used for western blot according Amersham Biosciences.
Acceptor photo-bleaching fo¨rster resonance energy transfer (fret). The acceptor
photo-bleaching method of FRET was used to study protein-protein interaction. We
used CFP-Beclin 1 and VMP1-YFP constructs. Conditions establishing that the
Beclin 1 and VMP1 constructs behaved similarly to wild-type non-fluorescent tagged
proteins were previously reported12. In FRET analysis, an acceptor fluorescent
molecule can be quenched and causes fluorescence of a donor molecule if the
respective proteins of interested tagged with each fluorescent molecule are closed
enough. FRET between CFP-Beclin 1 (donor) and VMP1-YFP (acceptor) was
performed using the acceptor photo-bleaching method on an Olympus FV1000
confocal microscope outlined in the FV10 Olympus software. HeLa cells were
transiently transfected with CFP-Beclin 1 or CFP-Beclin 1-BD and VMP1-YFP using
FuGENE-6 (Promega). 24 h after transfection, cells were fixed with 4%
paraformaldehyde and mounted with DABCO. A UPLSAPO 60X O NA: 1.35
objective was used. Regions of interest (ROI) were selected and images collected
before and after bleaching with the 514 nm laser line at maximum intensity (100%).
Excitation wavelength was 458 nm for CFP and 514 nm for YFP. Emission
wavelength was BP 465–510 nm for CFP and 518–561 nm for YFP. The change in the
fluorescence intensity between pre- and post-bleach donor values (efficiency, E) was
calculated using the formula E5 Fpre/Fpost, and was shown as a percentage.
Beclin 1 constructions. Beclin 1 coding sequence was cloned in the expression
plasmid pET22b. The pET22b vector contains a poly-His sequence that is added to
the carboxy terminal end of the peptide to facilitate its purification. We generated the
following constructions: pET22-Beclin1/BH3 (Beclin1 amino terminal domain; aa 1-
123), pET22-Beclin1/CCD (BH3 domain and CCD domain; aa 1-269) and pET22/
Beclin1 (complete protein; aa 1-450). The constructions were used in induction assays
performed in the bacterial strain BL21 (DE3) Codon plus RIL. This strain contains an
extra plasmid that codifies for rare tRNA codons of Arg, Ile and Leu, which work to
express proteins in mammals. For the induction assays, bacteria’s were transformed
by the heat shock method, and then grown overnight (ON) in LB medium. Clones
were selected for miniexpression assays. Bacteria culture of each clone was grown and
expression was induced by the addition of the lactose analogue IPTG (2 mM).
Cultures were grown for 4 h. The bacterial pellets were then lysed with lysozime
1 mg/ml and a buffer containing NaH2PO4 50 mM, NaCl 300 mM, histidine 10 mM
pH8. Finally, we obtained bacterial lysates containing the recombinant proteins
Beclin 1, Beclin1/CCD and Beclin1/BH3. In each case an aliquot of the lysate was used
to test the interaction with the VMP1-AtgD peptide (aa 386–406), in a pull-down
assay.
Immunofluorescence. After treatments, HeLa cells were fixed during 15 minutes
with 4% p-formaldehyde in PBS and immediately washed several times with PBS.
Cells were incubated with primary antibodies overnight at 4uC, according to
manufacturer. Rabbit anti-mouse Alexa Fluor 594 antibody was used for
immunofluorescence. Samples were mounted in DABCO (Sigma-Aldrich) with
DAPI (Sigma-Aldrich) as nuclear marker and observed in an inverted LSMOlympus
FV1000 using an UPLSAPO 60X O NA: 1.35 objectives.
Fluorescencemicroscopy.After transfection, cells were fixed during 15 minutes with
4% p-formaldehyde in PBS and immediately washed several times with PBS. Samples
were mounted in DABCO (Sigma-Aldrich) with DAPI (Sigma-Aldrich) as nuclear
marker and observed in an inverted LSM Olympus FV1000 using an UPLSAPO 60X
ONA: 1.35 objective and in a fluorescence microscope Nikon Eclypse 200 (Plan100).
To evaluate colocalization, we used the Olympus software Colocalization Scatterplot
coordinate system.
Coprecipitation assays. Cells were lysed (Lysis buffer: 50 mM Na2HPO4, 300 mM
NaCl, pH 8.0, 0.5% Tween-20, 0.5% Triton X-100, 10 mM imidazole) and cell lysates
were incubated with 50 ml of supermagnetics beads (Sigma-Aldrich) ON at 4uC;
afterwards the supernatant was removed using a magnetic device (MPC, Dynal Inc.)
and saved as unbound fraction. The beads were intensively washed with lysis buffer
and 20 mM imidazole. We eluted the bounded proteins with lysis buffer
supplemented with 200 mM imidazole. Samples were resolved on SDS-PAGE, and
detected by the appropriate antibodies. Transfected cells were lysed (Lysis buffer:
50 mM Na2HPO4, 300 mM NaCl, pH 8.0, 0.5% Tween-20, 0.5% Triton X-100,
10 mM imidazole) and cell lysates were incubated for 20-min at 4uC, followed by a
30-min centrifugation at 14000 rpm. The supernatants containing His-tagged
proteins were saved as unbound fraction. Ni-NTA beads were intensively washed
with washed buffer (50 mM tris pH 8.0 and 120 mMNaCl). The bound proteins were
eluted with lysis buffer supplementedwith 200 mM imidazole. Samples were resolved
on SDS-PAGE, and detected by immunoblotting. Protein expression levels were
quantified using the ImageJ densitometry; gel analyzer command. For silver nitrate
staining after SDS-PAGE gels were fixed in 30% ethanol, 10% acetic acid. Then, gels
were impregnate with 12 mM silver nitrate.When the adequate degree of staining has
been achieved, transfer the gel to the Tris stop solution.
Pull-down assays. Lysates were incubated with a nickel-agarose matrix (Qiagen)
during 24 h. The matrix was then washed with a buffer (NaH2PO4 50 mM and NaCl
300 mM pH 8.0). Then the VMP1 recombinant peptide (VMP1-AtgD) was added
when corresponding and the system was incubated for 24 h. Next, supernatant was
separated (L), and after three successive washes, we proceeded to the elution step of
the retained complex by adding a buffer with an excess of histidine. Finally, we
evaluated the presence of the VMP1-AtgD peptide and the recombinant Beclin 1
fragment by western Blot assays.
Statistical analysis. Data are expressed as mean 6 SD. Student’s t test was used for
comparisons between 2 groups and ANOVA test to assess more than 2 groups.
Differences were considered significant when p ,0.05.
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